APA (7th ed.) Citation

BY, C., JR, S., AO, T., A, P. R., JE, T., M, G., . . . PM, C. (2023). Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis. Immunology, 168(1), 152. https://doi.org/10.1111/imm.13569

Chicago Style (17th ed.) Citation

BY, Chen, et al. "Targeting Deoxycytidine Kinase Improves Symptoms in Mouse Models of Multiple Sclerosis." Immunology 168, no. 1 (2023): 152. https://doi.org/10.1111/imm.13569.

MLA (9th ed.) Citation

BY, Chen, et al. "Targeting Deoxycytidine Kinase Improves Symptoms in Mouse Models of Multiple Sclerosis." Immunology, vol. 168, no. 1, 2023, p. 152, https://doi.org/10.1111/imm.13569.